LLY-2707

• Description:

  LLY-2707 is a selective glucocorticoid receptor (GR) antagonist. LLY-2707 is promising for research of diabetes and psychiatric disorders such as schizophrenia[1].

• UNSPSC:

  12352005

• Target:

  Glucocorticoid Receptor

• Related Pathways:

  Immunology/Inflammation; Vitamin D Related/Nuclear Receptor

• Field of Research:

  Metabolic Disease; Neurological Disease

• Smiles:

  CS(=O)(NC1=CC(C(C)(C)C)=CC2=C1NC(C)=C2C3=CC(F)=NC=C3C)=O

• Molecular Formula:

  C20H24FN3O2S

• Molecular Weight:

  389.49

• References & Citations:

  [1]Sindelar DK, et al. LLY-2707, a novel nonsteroidal glucocorticoid antagonist that reduces atypical antipsychotic-associated weight gain in rats. J Pharmacol Exp Ther. 2014 Jan;348 (1) :192-201.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  1621865-33-5